Sentante Endovascular Robotic Platform

Organization
Sentante · Lithuania
Solution Type
Ready Product / Solution
Collaboration
Business Collaboration (Joint Venture), Licensing

1. Technology overview

Sentante, operated by UAB Inovatyvi Medicina (Vytauto pr. 23, Kaunas, Lithuania), develops robotic systems for endovascular interventions. The company states it was founded in 2017 and its work is co-financed under EU projects for a neurovascular robotic system and a digital inflator.

The platform is a haptic, device-agnostic robot for catheter and guidewire procedures, with a bedside unit in the operating room and a control suite. It senses force and torque at the catheter drive, uses a 1:1 motion-mimicking interface so interventionalists can operate without retraining, and records force, kinematics and time-aligned fluoroscopy for each procedure. The CE mark was announced in May 2026.

2. Highlighted features & specifications

  • Haptic control: force and torque sensing at the catheter drive.
  • Motion mimicking: 1:1 interface that follows the operator's hand movements.
  • Device agnostic: works with standard catheters and guidewires.
  • Data capture: records force, kinematics and time-aligned fluoroscopy.
  • Edge compute: NVIDIA Jetson AGX integrated in the latest robot.
  • Applications: peripheral arterial intervention, embolisation and interventional oncology.

3. Potential application

Large Vietnamese hospitals with cath labs can evaluate the platform for peripheral arterial intervention and embolisation. Interventional oncology units can use it for embolisation procedures. Training centers can use recorded force data for operator skill assessment.

4. Benefits

Gives force-aware, consistent catheter handling in endovascular procedures. Lets existing interventionalists operate without retraining through a 1:1 motion-mimicking interface. Works with standard catheter and guidewire portfolios and fits existing cath-lab infrastructure. Records procedure data intended to support future AI capabilities.

6. Other information

Legal entity UAB Inovatyvi Medicina, Kaunas. CE mark May 2026; FDA Breakthrough Device Designation for the remote stroke programme in September 2025. Two EU-co-financed projects listed (about EUR 2.0M and EUR 0.87M EU funding). NVIDIA Inception member. Discovered via EIC-related lists; the site does not mention EIC Accelerator.

Not ready to connect yet?

Save this solution and come back when you are ready to talk to the provider

Trusted by Our Partners

TechFest VietnamIOM – UN MigrationGIZ (Deutsche Gesellschaft für Internationale Zusammenarbeit)APED – Cục Phát triển doanh nghiệp tư nhân và kinh tế tập thểSIHUB – Startup and Innovation Hub of Ho Chi Minh CityHợp tác Đức (Deutsche Zusammenarbeit)SCE & Investment PromotionStartup Vietnam Foundation (SVF)National Startup Support Center (NSSC)01BoosterQuest VenturesBộ Tài chính (Ministry of Finance)ITPC – HCMC Investment and Trade Promotion CentreJICA – Japan International Cooperation AgencyNational Innovation Center (NIC)UK GovernmentBCG – Boston Consulting GroupHAWEEHeineken VietnamTalentnetMB BankVIREA – Liên chi hội Bất động sản Công nghiệp Việt NamJobTestGlobal Supply Chain Support Fund / Aavishkaar CapitalKDANPSE / JPS – Phúc Sang MinhG-AsiaPacificBlueScopeLPBankUlsan Center for Creative Economy & InnovationĐại học Bách khoa Hà Nội – Trường Điện - Điện tửVINK – Vietnam Innovation Network in KoreaTencent WeStart (Shenzhen)Ulsan CollegeK-StartupFaslinkShinhan Future's LabShinhan SecuritiesShinhan FinanceShinhan BankShinhan Life

Start with the right connection

We make innovation easy to access for every business everywhere. The next deal is you.

Contact Us